Stability and Predictability of Motor Symptom Control in Patients with Advanced Parkinson's Disease (aPD) Receiving Continuous Subcutaneous Foslevodopa/Foscarbidopa (LDP/CDP)

被引：0
|
作者：
Pahwa, R.
Malaty, I.
Soileau, M.
Fung, V.
Garcia, D. Santos
Carroll, C.
Henriksen, T.
Epstein, A.
Yan, C.
Alobaidi, A.
Shewale, A.
Spiegel, A.
Facheris, M.
Shah, M.
Kukreja, P.
Zamudio, J.
Chaudhuri, K.
机构：
来源：
MOVEMENT DISORDERS | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
105
引用
收藏
页码：S44 / S45
页数：2
相关论文
共 50 条
  • [1] Foslevodopa/foscarbidopa (LDp/CDp) in advanced Parkinson's Disease (aPD): demonstration of savings from a societal perspective in the UK
    Chaudhuri, K. Ray
    Bergmann, Lars
    Belsey, Jonathan
    Boodhna, Trishal
    Leoncini, Emanuele
    JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 1267 - 1278
  • [2] Challenges with Oral Anti-Parkinsonian Medications and Opportunities with Continuous Subcutaneous Infusion (CSCI) Of Foslevodopa/Foscarbidopa (LDP/CDP) for Treatment of Advanced Parkinson's Disease (aPD)
    Aldred, J.
    Soileau, M.
    Yan, C.
    Brion, T.
    Bellenger, A.
    Suh, J.
    O'Donnell, C.
    Kukreja, P.
    Facheris, M.
    Shewale, A.
    Kumar, R.
    MOVEMENT DISORDERS, 2023, 38 : S8 - S9
  • [3] Predictability of Motor States With Foslevodopa/Foscarbidopa in Patients With Advanced Parkinson's disease (PD)
    Hauser, R.
    Bouchard, M.
    Santos-Garcia, D.
    Bergmann, L.
    Gupta, R.
    Harmer, L.
    Shah, M.
    Yan, C.
    Isaacson, S.
    MOVEMENT DISORDERS, 2024, 39 : S340 - S341
  • [4] Comparative-effectiveness of Foscarbidopa/Foslevodopa (LDp/CDp) Versus Oral Therapies in Advanced Parkinson's disease (PD): A Propensity Matched Study
    Standaert, D.
    Fasano, A.
    Ory-Magne, F.
    Kern, D.
    de Fabregues, O.
    Oeda, T.
    Safarpour, D.
    Baldwin, Z.
    Yan, C.
    Wang, S.
    Onuk, K.
    Kukreja, P.
    Bergmann, L.
    Fung, V.
    MOVEMENT DISORDERS, 2024, 39 : S372 - S373
  • [5] Continuous subcutaneous foslevodopa/foscarbidopa infusion for the treatment of motor fluctuations in Parkinson's disease: Considerations for initiation and maintenance
    Fung, Victor S. C.
    Aldred, Jason
    Arroyo, Martha P.
    Bergquist, Filip
    Boon, Agnita J. W.
    Bouchard, Manon
    Bray, Sarah
    Dhanani, Sara
    Facheris, Maurizio F.
    Fisseha, Nahome
    Freire-Alvarez, Eric
    Hauser, Robert A.
    Jeong, Anna
    Jia, Jia
    Kukreja, Pavnit
    Soileau, Michael J.
    Spiegel, Amy M.
    Talapala, Saritha
    Tarakad, Arjun
    Urrea-Mendoza, Enrique
    Zamudio, Jorge
    Pahwa, Rajesh
    CLINICAL PARKINSONISM & RELATED DISORDERS, 2024, 10
  • [6] Rapid onset of good ON time and improvement in motor-state stability in aPD patients after treatment with continuous subcutaneous foslevodopa/foscarbidopa
    Pahwa, R.
    Soileau, M.
    Standaert, D.
    Fung, V.
    Kimber, T.
    Malaty, I.
    Merola, A.
    Epstein, A.
    Yan, C.
    Alobaidi, A.
    Shewale, A.
    Fisseha, N.
    Jeong, A.
    Facheris, M.
    Kukreja, P.
    Zamudio, J.
    Aldred, J.
    MOVEMENT DISORDERS, 2022, 37 : S346 - S346
  • [7] EFFICACY AND SAFETY OF FOSLEVODOPA/FOSCARBIDOPA CONTINUOUS SUBCUTANEOUS INFUSION ADMINISTERED AS MONOTHERAPY IN PATIENTS WITH PARKINSON'S DISEASE
    Aldred, J.
    Henriksen, T.
    Bouchard, M.
    Martinez-Castrillo, J. C.
    Soileau, M. J.
    Spiegel, A.
    Bergmann, L.
    Gupta, R.
    Kukreja, P.
    Standaert, D. G.
    PARKINSONISM & RELATED DISORDERS, 2024, 122
  • [8] Efficacy and Safety of Foslevodopa/Foscarbidopa Continuous Subcutaneous Infusion Administered as Monotherapy in Patients with Parkinson's Disease
    Aldred, J.
    Henriksen, T.
    Bouchard, M.
    Martinez-Castrillo, J.
    Soileau, M.
    Spiegel, A.
    Bergmann, L.
    Gupta, R.
    Kukreja, P.
    Standaert, D.
    MOVEMENT DISORDERS, 2023, 38 : S7 - S8
  • [9] Effects of continuous subcutaneous infusion of foslevodopa/foscarbidopa on quality-of-life in Parkinson's patients
    Gandor, F.
    Bouchard, M.
    Bergmans, B.
    Pahwa, R.
    Isaacson, S.
    Spiegel, A.
    Bergmann, L.
    Jia, J.
    Shah, M.
    Antonini, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 304 - 304
  • [10] Effects of continuous subcutaneous infusion of foslevodopa/foscarbidopa on quality-of-life in Parkinson's patients
    Gandor, F.
    Bouchard, M.
    Bergmans, B.
    Pahwa, R.
    Isaacson, S.
    Spiegel, A.
    Bergmann, L.
    Jia, J.
    Shah, M.
    Waern, J.
    Antonini, A.
    AUSTRALASIAN JOURNAL ON AGEING, 2024, 43 : 32 - 32
12345